Form 4 for IDXX Idexx Laboratories
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-07 · accession 0000874716-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-10 | 2025-02-07 | IDXX | SZOSTAK M ANNE | Dir | S - Sale | $465.95 | -3,000 | 3,061 | -49% | -$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | S | D | 3,000 | $465.95 | 3,061 | I Trust of M. Anne Szostak | — | — | (F1) The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust. |